Lyse A. Norian

3.2k total citations
77 papers, 2.3k citations indexed

About

Lyse A. Norian is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Lyse A. Norian has authored 77 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 37 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in Lyse A. Norian's work include Cancer Immunotherapy and Biomarkers (21 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (16 papers). Lyse A. Norian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immune Cell Function and Interaction (19 papers) and Immunotherapy and Immune Responses (16 papers). Lyse A. Norian collaborates with scholars based in United States, Vietnam and Italy. Lyse A. Norian's co-authors include Gary A. Koretzky, Kevin Latinis, Paul M. Allen, Rebecca C. Arend, Steve Eliason, William J. Turbitt, Thomas S. Griffith, Tamara A. Kucaba, Leigh A. O’Mara and Marina Cella and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Lyse A. Norian

75 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyse A. Norian United States 28 1.0k 1.0k 748 367 301 77 2.3k
S. Jaharul Haque United States 28 981 1.0× 1.0k 1.0× 980 1.3× 433 1.2× 327 1.1× 58 2.5k
Jay Friedman United States 27 1.1k 1.0× 834 0.8× 1.2k 1.6× 355 1.0× 146 0.5× 55 2.6k
David R. Soto‐Pantoja United States 28 862 0.8× 1.0k 1.0× 494 0.7× 289 0.8× 324 1.1× 58 2.3k
Kazuko Saeki Japan 27 911 0.9× 978 1.0× 401 0.5× 239 0.7× 338 1.1× 53 2.3k
Kristine Kikly United States 22 2.1k 2.0× 1.0k 1.0× 643 0.9× 210 0.6× 230 0.8× 32 3.4k
Min Hee Oh United States 23 1.7k 1.6× 1.2k 1.1× 666 0.9× 743 2.0× 703 2.3× 44 3.7k
Xianying Xing United States 32 1.9k 1.8× 809 0.8× 431 0.6× 183 0.5× 411 1.4× 57 3.1k
Róisín M. Loftus Ireland 9 1.8k 1.8× 636 0.6× 586 0.8× 546 1.5× 179 0.6× 9 2.6k
Shadi Swaidani United States 21 1.4k 1.4× 631 0.6× 451 0.6× 305 0.8× 375 1.2× 35 2.4k
Yao-Chen Tsui United States 9 1.0k 1.0× 827 0.8× 593 0.8× 670 1.8× 110 0.4× 10 2.0k

Countries citing papers authored by Lyse A. Norian

Since Specialization
Citations

This map shows the geographic impact of Lyse A. Norian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyse A. Norian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyse A. Norian more than expected).

Fields of papers citing papers by Lyse A. Norian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyse A. Norian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyse A. Norian. The network helps show where Lyse A. Norian may publish in the future.

Co-authorship network of co-authors of Lyse A. Norian

This figure shows the co-authorship network connecting the top 25 collaborators of Lyse A. Norian. A scholar is included among the top collaborators of Lyse A. Norian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyse A. Norian. Lyse A. Norian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Zachary, et al.. (2024). An Exogenous Ketone Ester Slows Tumor Progression in Murine Breast and Renal Cancer Models. Cancers. 16(19). 3390–3390. 1 indexed citations
2.
Scalise, Carly Bess, Ashwini A. Katre, Selene Meza‐Perez, et al.. (2021). Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance. Gynecologic Oncology. 164(1). 170–180. 16 indexed citations
3.
4.
Turbitt, William J., Claire Buchta Rosean, K. Scott Weber, & Lyse A. Norian. (2020). Obesity and CD8 T cell metabolism: Implications for anti‐tumor immunity and cancer immunotherapy outcomes. Immunological Reviews. 295(1). 203–219. 41 indexed citations
5.
Wongrakpanich, Amaraporn, et al.. (2020). Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine. Bioconjugate Chemistry. 31(9). 2147–2157. 14 indexed citations
6.
Nam, Hyeyoung, Anirban Kundu, Garrett J. Brinkley, et al.. (2020). PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. Matrix Biology. 89. 43–58. 20 indexed citations
7.
Meza‐Perez, Selene, Ashwini A. Katre, Troy D. Randall, et al.. (2020). Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma. Molecular Cancer Therapeutics. 20(3). 602–611. 7 indexed citations
8.
Turbitt, William J., Justin T. Gibson, Shannon K. Boi, et al.. (2020). The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer. Cancers. 12(10). 2872–2872. 17 indexed citations
9.
Demark‐Wahnefried, Wendy, Laura Q. Rogers, Justin T. Gibson, et al.. (2019). Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics. International Journal of Cancer. 146(10). 2784–2796. 43 indexed citations
10.
Turbitt, William J., Wendy Demark‐Wahnefried, Courtney M. Peterson, & Lyse A. Norian. (2019). Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics. Frontiers in Immunology. 10. 1402–1402. 61 indexed citations
11.
Tobert, Conrad M., Jill Hamilton‐Reeves, Lyse A. Norian, et al.. (2017). Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer. The Journal of Urology. 198(3). 511–519. 61 indexed citations
12.
Janowski, Ann M., Oscar R. Colegio, Emma E. Hornick, et al.. (2016). NLRC4 suppresses melanoma tumor progression independently of inflammasome activation. Journal of Clinical Investigation. 126(10). 3917–3928. 63 indexed citations
13.
Hale, Malika, et al.. (2015). Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2. PLoS ONE. 10(3). e0118784–e0118784. 65 indexed citations
14.
Norian, Lyse A., Paulo C. Rodrı́guez, Leigh A. O’Mara, et al.. (2009). Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l -Arginine Metabolism. Cancer Research. 69(7). 3086–3094. 216 indexed citations
15.
O’Mara, Leigh A., et al.. (2005). T Cell-Mediated Delay of Spontaneous Mammary Tumor Onset: Increased Efficacy with In Vivo versus In Vitro Activation. The Journal of Immunology. 174(8). 4662–4669. 3 indexed citations
16.
Hanson, Holly L., Silvia S. Kang, Lyse A. Norian, et al.. (2004). CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+ T Cell Precursors. The Journal of Immunology. 172(7). 4215–4224. 26 indexed citations
17.
Norian, Lyse A. & Paul M. Allen. (2004). No Intrinsic Deficiencies in CD8+ T Cell-Mediated Antitumor Immunity with Aging. The Journal of Immunology. 173(2). 835–844. 22 indexed citations
18.
Norian, Lyse A., Kevin Latinis, Steve Eliason, et al.. (2000). The Regulation of CD95 (Fas) Ligand Expression in Primary T Cells: Induction of Promoter Activation in CD95LP-Luc Transgenic Mice. The Journal of Immunology. 164(9). 4471–4480. 16 indexed citations
19.
Cowdery, John S., Nancy J. Boerth, Lyse A. Norian, Peggy Myung, & Gary A. Koretzky. (1999). Differential Regulation of the IL-12 p40 Promoter and of p40 Secretion by CpG DNA and Lipopolysaccharide. The Journal of Immunology. 162(11). 6770–6775. 58 indexed citations
20.
Norian, Lyse A., Kevin Latinis, & Gary A. Koretzky. (1998). A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes.. PubMed. 161(3). 1078–82. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Jaharul Haque Breakdown of academic impact, for papers by Jay Friedman Breakdown of academic impact, for papers by David R. Soto‐Pantoja Breakdown of academic impact, for papers by Kazuko Saeki Breakdown of academic impact, for papers by Kristine Kikly Breakdown of academic impact, for papers by Min Hee Oh Breakdown of academic impact, for papers by Xianying Xing Breakdown of academic impact, for papers by Róisín M. Loftus Breakdown of academic impact, for papers by Shadi Swaidani Breakdown of academic impact, for papers by Yao-Chen Tsui
Rankless by CCL
2026